Piper Heartland Healthcare Capital

Piper Heartland Healthcare Capital is a private equity firm specializing in healthcare investments. It aligns the knowledge, expertise, and capital of Piper Sandler with the interests of its limited partners to invest in innovative healthcare companies at key moments in their growth path. This combination allows the firm to pursue proprietary investment opportunities and deliver exceptional potential returns for investors.

The firm's flagship fund, the Piper Heartland Healthcare Crossover Fund, is a dedicated healthcare investment fund with over $200 million in committed capital. It focuses on innovative companies with near-term public market prospects, driven by experienced management teams and backed by highly respected investment partners. The fund primarily invests in biotech, med-tech, and healthcare information sectors, leveraging Piper Sandler's leading healthcare banking and research platforms. The firm has made several investments, including in companies like Kardium, OrganOx, AdvanCell, Saluda Medical, Alentis Therapeutics, Epic Bio, Alumis, ProfoundBio, Avalyn Pharma, Boundless Bio, Cargo Therapeutics, Metagenomi, Cleerly, Bicara Therapeutics, Structure Therapeutics, and Endeavor BioMedicines.

The leadership team includes Matt Hemsley as CEO, Ahmad El Naggar as Director, Trent Holland as Vice President, and John Snodgrass as Associate.